Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 11, keine Gesamtzahl für „section“
Suchtreffer
Begriffe & Kennungen
Baraclude · 4.5 · Entecavir is not a substrate, an inducer or an inhibitor of cytochrome P450 (CYP450) enzymes (see section 5.2)
Eintrag öffnenBaraclude · 4.5 · Since entecavir is predominantly eliminated by the kidney (see section 5.2), coadministration with medicinal p
Eintrag öffnenBaraclude · 4.5 · Since entecavir is predominantly eliminated by the kidney (see section 5.2), coadministration with medicinal p
Eintrag öffnenBavencio · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenBavencio · 4.8 · The management guidelines for these adverse reactions are described in section 4.4.
Eintrag öffnenBekemv · 4.3 · BEKEMV therapy must not be initiated in patients (see section 4.4): - with unresolved Neisseria meningitidis i
Eintrag öffnenBekemv · 4.3 · Hypersensitivity to eculizumab or to any of the excipients listed in section 6.1.
Eintrag öffnenBemfola · 4.3 · • hypersensitivity to the active substance or to any of the excipients listed in section 6.1; • tumours of the
Eintrag öffnenBemfola · 4.8 · Thromboembolism may occur very rarely (see section 4.4).
Eintrag öffnenBeneFIX · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenBeneFIX · 4.8 · There are insufficient data to provide information on inhibitor incidence in PUPs (see also section 5.1).
Eintrag öffnenBenlysta · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenBenlysta · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenBenlysta · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenBenlysta · 4.8 · For information on infections observed in paediatric patients with SLE see Paediatric population section below
Eintrag öffnenBenlysta · 4.8 · For information on infections observed in paediatric patients with SLE see Paediatric population section below
Eintrag öffnenBenlysta · 4.8 · For information on infections observed in paediatric patients with SLE see Paediatric population section below
Eintrag öffnenBenlysta · 4.8 · In the lupus nephritis study, patients were receiving a background of standard therapy (see section 5.1) and t
Eintrag öffnenBenlysta · 4.8 · In the lupus nephritis study, patients were receiving a background of standard therapy (see section 5.1) and t
Eintrag öffnenBenlysta · 4.8 · In the lupus nephritis study, patients were receiving a background of standard therapy (see section 5.1) and t
Eintrag öffnen